WallStreetZenWallStreetZen

NASDAQ: ADUS
Addus Homecare Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ADUS

Based on 7 analysts offering 12 month price targets for Addus Homecare Corp

Min Forecast
$117.00-2.39%
Avg Forecast
$137.00+14.3%
Max Forecast
$150.00+25.15%

Should I buy or sell ADUS stock?

Based on 7 analysts offering ratings for Addus Homecare Corp.

Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 14.29%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ADUS stock forecasts and price targets.

ADUS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-05
lockedlocked$00.00+00.00%2025-11-04
lockedlocked$00.00+00.00%2025-09-03
lockedlocked$00.00+00.00%2025-09-02
lockedlocked$00.00+00.00%2025-08-22
JMP Securities
Bottom 1%
1
BuyReiterates$150.00+25.15%2025-07-16
Macquarie
Top 18%
83
BuyMaintains$133.00+10.96%2025-06-10

1 of 1

Forecast return on equity

Is ADUS forecast to generate an efficient return?

Company
13.37%
Industry
-76.61%
Market
338.14%
ADUS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ADUS forecast to generate an efficient return on assets?

Company
9.86%
Industry
10%
ADUS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ADUS earnings per share forecast

What is ADUS's earnings per share in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$6.20+30.55%
Avg 2 year Forecast
$6.88+44.78%
Avg 3 year Forecast
$7.59+59.87%
ADUS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ADUS revenue forecast

What is ADUS's revenue in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$1.4B+6.56%
Avg 2 year Forecast
$1.5B+13.62%
Avg 3 year Forecast
$1.6B+19.56%
ADUS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ADUS earnings growth forecast

How is ADUS forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
20.42%
Industry
14.71%
Market
101.85%
ADUS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ADUS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ADUS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ADUS revenue growth forecast

How is ADUS forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
6.45%
Industry
4.33%
Market
58.91%
ADUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ADUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ADUS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
ADUS$119.86$137.00+14.30%Buy
BKD$9.27$8.50-8.31%Buy
ARDT$14.67$17.80+21.34%Buy
CON$19.14$31.00+61.96%Strong Buy
PACS$12.84N/AN/A
View Top Medical Care Facility Stocks

Addus Homecare Stock Forecast FAQ

Is Addus Homecare Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: ADUS) stock is to Buy ADUS stock.

Out of 7 analysts, 3 (42.86%) are recommending ADUS as a Strong Buy, 3 (42.86%) are recommending ADUS as a Buy, 0 (0%) are recommending ADUS as a Hold, 0 (0%) are recommending ADUS as a Sell, and 1 (14.29%) are recommending ADUS as a Strong Sell.

If you're new to stock investing, here's how to buy Addus Homecare stock.

What is ADUS's earnings growth forecast for 2025-2027?

(NASDAQ: ADUS) Addus Homecare's forecast annual earnings growth rate of 20.42% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 14.71%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 101.85%.

Addus Homecare's earnings in 2025 is $85,654,000.On average, 14 Wall Street analysts forecast ADUS's earnings for 2025 to be $114,612,915, with the lowest ADUS earnings forecast at $92,976,398, and the highest ADUS earnings forecast at $122,072,763. On average, 14 Wall Street analysts forecast ADUS's earnings for 2026 to be $127,111,303, with the lowest ADUS earnings forecast at $102,794,712, and the highest ADUS earnings forecast at $138,180,934.

In 2027, ADUS is forecast to generate $140,360,112 in earnings, with the lowest earnings forecast at $132,229,321 and the highest earnings forecast at $149,243,172.

What is ADUS's revenue growth forecast for 2025-2027?

(NASDAQ: ADUS) Addus Homecare's forecast annual revenue growth rate of 6.45% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.91%.

Addus Homecare's revenue in 2025 is $1,346,596,000.On average, 13 Wall Street analysts forecast ADUS's revenue for 2025 to be $26,523,493,885, with the lowest ADUS revenue forecast at $25,340,564,541, and the highest ADUS revenue forecast at $27,503,107,248. On average, 13 Wall Street analysts forecast ADUS's revenue for 2026 to be $28,279,404,630, with the lowest ADUS revenue forecast at $26,505,010,614, and the highest ADUS revenue forecast at $29,702,616,497.

In 2027, ADUS is forecast to generate $29,758,066,310 in revenue, with the lowest revenue forecast at $27,540,073,790 and the highest revenue forecast at $31,883,642,475.

What is ADUS's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ADUS) forecast ROA is 9.86%, which is lower than the forecast US Medical Care Facilities industry average of 10%.

What is ADUS's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ADUS price target, the average ADUS price target is $137.00, with the highest ADUS stock price forecast at $150.00 and the lowest ADUS stock price forecast at $117.00.

On average, Wall Street analysts predict that Addus Homecare's share price could reach $137.00 by Nov 5, 2026. The average Addus Homecare stock price prediction forecasts a potential upside of 14.3% from the current ADUS share price of $119.86.

What is ADUS's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ADUS) Addus Homecare's current Earnings Per Share (EPS) is $4.75. On average, analysts forecast that ADUS's EPS will be $6.20 for 2025, with the lowest EPS forecast at $5.03, and the highest EPS forecast at $6.60. On average, analysts forecast that ADUS's EPS will be $6.88 for 2026, with the lowest EPS forecast at $5.56, and the highest EPS forecast at $7.48. In 2027, ADUS's EPS is forecast to hit $7.59 (min: $7.15, max: $8.07).

What is ADUS's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ADUS) forecast ROE is 13.37%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.